書誌事項
- タイトル別名
-
- Susceptibility testing of antimicrobial agents against CTX-M-2 group .BETA.-lactamase producing Proteus mirabilis isolated from clinical specimens
この論文をさがす
抄録
MICs of antimicrobial agents were tested against CTX-M-2 group β-lactamase producing ESBL Proteus mirabilis isolated from 148 clinical specimens gathered from May to July 2005.<BR>MICK90 of ceftibuten (1μg/mL), ceftazidime (0.5μg/mL), cefmetazole (4μg/mL), latamoxef (≤0.25μg/mL), imipenem (2μg/mL), meropenem (≤0.25μg/mL), and aztreonam (2μg/mL) indicated high susceptibility toward these agents. Ampicillin, piperacillin, cefazolin, and cefotaxime showed very high MIC90s (≥256μg/mL).<BR>MIC90 of minocycline was high (128μg/mL), whereas those of aminoglycosides amikacin, tobramycin, and gentamicin were 8, 16, and 16μg/mL. MICs of quinolones levofloxacin, ciprofloxacin, and gatifloxacin fluctuated widely from≤0.25-≥256μg/mL, ≤0.25-≥256μg/mL, and≤0.25-128μg/mL for each agent.<BR>Infection control of ESBL producing gram-negative rods is very important at a medical institution. Furthermore, susceptibility tests play an important role in the implementation of effective control measures.
収録刊行物
-
- 日本化学療法学会雑誌
-
日本化学療法学会雑誌 54 (5), 447-452, 2006
公益社団法人 日本化学療法学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001206285708544
-
- NII論文ID
- 130004298304
- 10018040971
-
- NII書誌ID
- AN10472127
-
- ISSN
- 18845886
- 13407007
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可